This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Legend Biotech Ireland Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Ruidong Hao: Innovator in Cancer Treatment
Introduction
Ruidong Hao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment through his innovative work on chimeric antigen receptors.
Latest Patents
Ruidong Hao holds a patent for "Anti-DLL3 chimeric antigen receptors and uses thereof." This patent focuses on the development of anti-DLL3 chimeric antigen receptors (CARs) and DLL3 binding proteins. These innovations are aimed at treating DLL3 associated disorders, particularly small cell lung cancer.
Career Highlights
Ruidong Hao is currently employed at Legend Biotech Ireland Limited, where he continues to advance research in the field of immunotherapy. His work has the potential to significantly impact the treatment landscape for patients suffering from aggressive forms of cancer.
Collaborations
Ruidong collaborates with notable colleagues, including Tao Zhao and Yuanyuan Peng, who contribute to his research efforts and innovations.
Conclusion
Ruidong Hao's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His contributions are paving the way for new therapeutic approaches that could benefit many patients in need.